Milestone Moment for Pandemic Treaty in Geneva – US and Other Treaty Skeptics Swinging Behind Call to Negotiate a New Convention 26/11/2021 Elaine Ruth Fletcher As pandemic treaty negotiations kick off again at the World Health Organization (WHO) in Geneva this week, countries face a stark choice. Will they decide to move ahead on a new system that vests an independent entity with greater powers to monitor their own national alert and responses – in the name of faster pandemic […] Continue reading -> ‘Omicron’: New COVID-19 Variant With Multiple Concerning Mutations Identified in Southern Africa – USA & Europe Respond With Flurry of Travel Restrictions 25/11/2021 Kerry Cullinan CAPE TOWN – A new COVID-19 variant with a “very unusual constellation of mutations” – currently referred to as B.1.1.529 – has been identified in southern Africa, South Africa’s Health Ministry announced on Thursday. On Friday, WHO dubbed the variant “Omicron”, adding it to its list of variants of concern – even as the European […] Continue reading -> Russia Says Sputnik COVID-19 Vaccine Shows Better Efficacy Than mRNA Vaccines 24/11/2021 Raisa Santos Russia’s Sputnik V COVID-19 vaccine demonstrates an 80% efficacy six to eight months after the second dose – a higher efficacy than officially published mRNA vaccines, announced the Russian Direct Investment Fund (RDIF) in a press briefing on Wednesday. The efficacy data is based on “real-world data from the Ministry of Health of the Republic […] Continue reading -> C-TAP and Medicines Patent Pool Announce Global License for Spanish COVID-19 Test 23/11/2021 Raisa Santos The first non-exclusive license for a COVID-19 health tool – a serological antibody test that checks for the presence of anti-SARS-CoV-2 antibodies – has been finalised by the World Health Organization’s (WHO) COVID-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP). The license, announced on Tuesday in partnership with the Spanish National Research […] Continue reading -> United States FDA Clears COVID Vaccine Boosters for All Adults Over 18 – Pfizer & Moderna 6 Months After Second Jab 19/11/2021 Elaine Ruth Fletcher The United States Food and Drug Administration (US FDA) on Friday gave its greenlight to the mass rollout of both Pfizer and Moderna COVID booster shots to all adults over the age of 18, from six months after a person’s second vaccine dose. J&J vaccine boosters would be authorized after just two months of the […] Continue reading -> Half the People Living with Diabetes Can’t Afford Insulin, WHO Report Shows 13/11/2021 Aishwarya Tendolkar The inflated costs of insulin and control of its price and supply – are barriers preventing people with diabetes from accessing this life-saving medicine, according to a report released by the World Health Organization (WHO). Insulin is the basis of diabetes treatment, essential for nine million people with type 1 diabetes who cannot make […] Continue reading -> India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> Pakistan, Afghanistan & Yemen Among Countries With Biggest Vaccine Supply Gaps; US Promises More Jabs for Conflict Zones 11/11/2021 Elaine Ruth Fletcher Pakistan and eight other countries, mostly in or around conflict zones, face the largest gaps in vaccine commitments needed to reach a WHO goal of 70% coverage by September 2022. The data is part of a new “COVID Global Tracker” – launched Wednesday during a first-ever meeting of the world’s foreign ministers, convened by US […] Continue reading -> Launching the ‘African Medicines Agency Countdown’ 05/11/2021 Editorial team More than half of the African Union’s 55 member states have now signed the African Medicines Agency Treaty. As the countdown begins for other nations to sign, Health Policy Watch will be keeping track on our newly-launched AMA Countdown, website developed in collaboration with the African Medicines Agency Treaty Alliance. Here you can find the […] Continue reading -> ‘Zero Draft’ Report on WHO Reform Punts Pandemic Treaty Forward – Amidst Signals of US Warming to Initiative 28/10/2021 Elaine Ruth Fletcher A “Zero Draft” report by a WHO Working Group gives cautious endorsement to advancing negotiations over a new “Pandemic Treaty” among WHO’s 194 member states. That endorsement by the Working Group of member states remains couched in highly nuanced, diplomatic language that makes it clear how big the lift may be to actually negotiate a […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... Write a Comment... Email (Required) Name (Required) Website
‘Omicron’: New COVID-19 Variant With Multiple Concerning Mutations Identified in Southern Africa – USA & Europe Respond With Flurry of Travel Restrictions 25/11/2021 Kerry Cullinan CAPE TOWN – A new COVID-19 variant with a “very unusual constellation of mutations” – currently referred to as B.1.1.529 – has been identified in southern Africa, South Africa’s Health Ministry announced on Thursday. On Friday, WHO dubbed the variant “Omicron”, adding it to its list of variants of concern – even as the European […] Continue reading -> Russia Says Sputnik COVID-19 Vaccine Shows Better Efficacy Than mRNA Vaccines 24/11/2021 Raisa Santos Russia’s Sputnik V COVID-19 vaccine demonstrates an 80% efficacy six to eight months after the second dose – a higher efficacy than officially published mRNA vaccines, announced the Russian Direct Investment Fund (RDIF) in a press briefing on Wednesday. The efficacy data is based on “real-world data from the Ministry of Health of the Republic […] Continue reading -> C-TAP and Medicines Patent Pool Announce Global License for Spanish COVID-19 Test 23/11/2021 Raisa Santos The first non-exclusive license for a COVID-19 health tool – a serological antibody test that checks for the presence of anti-SARS-CoV-2 antibodies – has been finalised by the World Health Organization’s (WHO) COVID-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP). The license, announced on Tuesday in partnership with the Spanish National Research […] Continue reading -> United States FDA Clears COVID Vaccine Boosters for All Adults Over 18 – Pfizer & Moderna 6 Months After Second Jab 19/11/2021 Elaine Ruth Fletcher The United States Food and Drug Administration (US FDA) on Friday gave its greenlight to the mass rollout of both Pfizer and Moderna COVID booster shots to all adults over the age of 18, from six months after a person’s second vaccine dose. J&J vaccine boosters would be authorized after just two months of the […] Continue reading -> Half the People Living with Diabetes Can’t Afford Insulin, WHO Report Shows 13/11/2021 Aishwarya Tendolkar The inflated costs of insulin and control of its price and supply – are barriers preventing people with diabetes from accessing this life-saving medicine, according to a report released by the World Health Organization (WHO). Insulin is the basis of diabetes treatment, essential for nine million people with type 1 diabetes who cannot make […] Continue reading -> India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> Pakistan, Afghanistan & Yemen Among Countries With Biggest Vaccine Supply Gaps; US Promises More Jabs for Conflict Zones 11/11/2021 Elaine Ruth Fletcher Pakistan and eight other countries, mostly in or around conflict zones, face the largest gaps in vaccine commitments needed to reach a WHO goal of 70% coverage by September 2022. The data is part of a new “COVID Global Tracker” – launched Wednesday during a first-ever meeting of the world’s foreign ministers, convened by US […] Continue reading -> Launching the ‘African Medicines Agency Countdown’ 05/11/2021 Editorial team More than half of the African Union’s 55 member states have now signed the African Medicines Agency Treaty. As the countdown begins for other nations to sign, Health Policy Watch will be keeping track on our newly-launched AMA Countdown, website developed in collaboration with the African Medicines Agency Treaty Alliance. Here you can find the […] Continue reading -> ‘Zero Draft’ Report on WHO Reform Punts Pandemic Treaty Forward – Amidst Signals of US Warming to Initiative 28/10/2021 Elaine Ruth Fletcher A “Zero Draft” report by a WHO Working Group gives cautious endorsement to advancing negotiations over a new “Pandemic Treaty” among WHO’s 194 member states. That endorsement by the Working Group of member states remains couched in highly nuanced, diplomatic language that makes it clear how big the lift may be to actually negotiate a […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... Write a Comment... Email (Required) Name (Required) Website
Russia Says Sputnik COVID-19 Vaccine Shows Better Efficacy Than mRNA Vaccines 24/11/2021 Raisa Santos Russia’s Sputnik V COVID-19 vaccine demonstrates an 80% efficacy six to eight months after the second dose – a higher efficacy than officially published mRNA vaccines, announced the Russian Direct Investment Fund (RDIF) in a press briefing on Wednesday. The efficacy data is based on “real-world data from the Ministry of Health of the Republic […] Continue reading -> C-TAP and Medicines Patent Pool Announce Global License for Spanish COVID-19 Test 23/11/2021 Raisa Santos The first non-exclusive license for a COVID-19 health tool – a serological antibody test that checks for the presence of anti-SARS-CoV-2 antibodies – has been finalised by the World Health Organization’s (WHO) COVID-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP). The license, announced on Tuesday in partnership with the Spanish National Research […] Continue reading -> United States FDA Clears COVID Vaccine Boosters for All Adults Over 18 – Pfizer & Moderna 6 Months After Second Jab 19/11/2021 Elaine Ruth Fletcher The United States Food and Drug Administration (US FDA) on Friday gave its greenlight to the mass rollout of both Pfizer and Moderna COVID booster shots to all adults over the age of 18, from six months after a person’s second vaccine dose. J&J vaccine boosters would be authorized after just two months of the […] Continue reading -> Half the People Living with Diabetes Can’t Afford Insulin, WHO Report Shows 13/11/2021 Aishwarya Tendolkar The inflated costs of insulin and control of its price and supply – are barriers preventing people with diabetes from accessing this life-saving medicine, according to a report released by the World Health Organization (WHO). Insulin is the basis of diabetes treatment, essential for nine million people with type 1 diabetes who cannot make […] Continue reading -> India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> Pakistan, Afghanistan & Yemen Among Countries With Biggest Vaccine Supply Gaps; US Promises More Jabs for Conflict Zones 11/11/2021 Elaine Ruth Fletcher Pakistan and eight other countries, mostly in or around conflict zones, face the largest gaps in vaccine commitments needed to reach a WHO goal of 70% coverage by September 2022. The data is part of a new “COVID Global Tracker” – launched Wednesday during a first-ever meeting of the world’s foreign ministers, convened by US […] Continue reading -> Launching the ‘African Medicines Agency Countdown’ 05/11/2021 Editorial team More than half of the African Union’s 55 member states have now signed the African Medicines Agency Treaty. As the countdown begins for other nations to sign, Health Policy Watch will be keeping track on our newly-launched AMA Countdown, website developed in collaboration with the African Medicines Agency Treaty Alliance. Here you can find the […] Continue reading -> ‘Zero Draft’ Report on WHO Reform Punts Pandemic Treaty Forward – Amidst Signals of US Warming to Initiative 28/10/2021 Elaine Ruth Fletcher A “Zero Draft” report by a WHO Working Group gives cautious endorsement to advancing negotiations over a new “Pandemic Treaty” among WHO’s 194 member states. That endorsement by the Working Group of member states remains couched in highly nuanced, diplomatic language that makes it clear how big the lift may be to actually negotiate a […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... Write a Comment... Email (Required) Name (Required) Website
C-TAP and Medicines Patent Pool Announce Global License for Spanish COVID-19 Test 23/11/2021 Raisa Santos The first non-exclusive license for a COVID-19 health tool – a serological antibody test that checks for the presence of anti-SARS-CoV-2 antibodies – has been finalised by the World Health Organization’s (WHO) COVID-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP). The license, announced on Tuesday in partnership with the Spanish National Research […] Continue reading -> United States FDA Clears COVID Vaccine Boosters for All Adults Over 18 – Pfizer & Moderna 6 Months After Second Jab 19/11/2021 Elaine Ruth Fletcher The United States Food and Drug Administration (US FDA) on Friday gave its greenlight to the mass rollout of both Pfizer and Moderna COVID booster shots to all adults over the age of 18, from six months after a person’s second vaccine dose. J&J vaccine boosters would be authorized after just two months of the […] Continue reading -> Half the People Living with Diabetes Can’t Afford Insulin, WHO Report Shows 13/11/2021 Aishwarya Tendolkar The inflated costs of insulin and control of its price and supply – are barriers preventing people with diabetes from accessing this life-saving medicine, according to a report released by the World Health Organization (WHO). Insulin is the basis of diabetes treatment, essential for nine million people with type 1 diabetes who cannot make […] Continue reading -> India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> Pakistan, Afghanistan & Yemen Among Countries With Biggest Vaccine Supply Gaps; US Promises More Jabs for Conflict Zones 11/11/2021 Elaine Ruth Fletcher Pakistan and eight other countries, mostly in or around conflict zones, face the largest gaps in vaccine commitments needed to reach a WHO goal of 70% coverage by September 2022. The data is part of a new “COVID Global Tracker” – launched Wednesday during a first-ever meeting of the world’s foreign ministers, convened by US […] Continue reading -> Launching the ‘African Medicines Agency Countdown’ 05/11/2021 Editorial team More than half of the African Union’s 55 member states have now signed the African Medicines Agency Treaty. As the countdown begins for other nations to sign, Health Policy Watch will be keeping track on our newly-launched AMA Countdown, website developed in collaboration with the African Medicines Agency Treaty Alliance. Here you can find the […] Continue reading -> ‘Zero Draft’ Report on WHO Reform Punts Pandemic Treaty Forward – Amidst Signals of US Warming to Initiative 28/10/2021 Elaine Ruth Fletcher A “Zero Draft” report by a WHO Working Group gives cautious endorsement to advancing negotiations over a new “Pandemic Treaty” among WHO’s 194 member states. That endorsement by the Working Group of member states remains couched in highly nuanced, diplomatic language that makes it clear how big the lift may be to actually negotiate a […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... Write a Comment... Email (Required) Name (Required) Website
United States FDA Clears COVID Vaccine Boosters for All Adults Over 18 – Pfizer & Moderna 6 Months After Second Jab 19/11/2021 Elaine Ruth Fletcher The United States Food and Drug Administration (US FDA) on Friday gave its greenlight to the mass rollout of both Pfizer and Moderna COVID booster shots to all adults over the age of 18, from six months after a person’s second vaccine dose. J&J vaccine boosters would be authorized after just two months of the […] Continue reading -> Half the People Living with Diabetes Can’t Afford Insulin, WHO Report Shows 13/11/2021 Aishwarya Tendolkar The inflated costs of insulin and control of its price and supply – are barriers preventing people with diabetes from accessing this life-saving medicine, according to a report released by the World Health Organization (WHO). Insulin is the basis of diabetes treatment, essential for nine million people with type 1 diabetes who cannot make […] Continue reading -> India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> Pakistan, Afghanistan & Yemen Among Countries With Biggest Vaccine Supply Gaps; US Promises More Jabs for Conflict Zones 11/11/2021 Elaine Ruth Fletcher Pakistan and eight other countries, mostly in or around conflict zones, face the largest gaps in vaccine commitments needed to reach a WHO goal of 70% coverage by September 2022. The data is part of a new “COVID Global Tracker” – launched Wednesday during a first-ever meeting of the world’s foreign ministers, convened by US […] Continue reading -> Launching the ‘African Medicines Agency Countdown’ 05/11/2021 Editorial team More than half of the African Union’s 55 member states have now signed the African Medicines Agency Treaty. As the countdown begins for other nations to sign, Health Policy Watch will be keeping track on our newly-launched AMA Countdown, website developed in collaboration with the African Medicines Agency Treaty Alliance. Here you can find the […] Continue reading -> ‘Zero Draft’ Report on WHO Reform Punts Pandemic Treaty Forward – Amidst Signals of US Warming to Initiative 28/10/2021 Elaine Ruth Fletcher A “Zero Draft” report by a WHO Working Group gives cautious endorsement to advancing negotiations over a new “Pandemic Treaty” among WHO’s 194 member states. That endorsement by the Working Group of member states remains couched in highly nuanced, diplomatic language that makes it clear how big the lift may be to actually negotiate a […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... Write a Comment... Email (Required) Name (Required) Website
Half the People Living with Diabetes Can’t Afford Insulin, WHO Report Shows 13/11/2021 Aishwarya Tendolkar The inflated costs of insulin and control of its price and supply – are barriers preventing people with diabetes from accessing this life-saving medicine, according to a report released by the World Health Organization (WHO). Insulin is the basis of diabetes treatment, essential for nine million people with type 1 diabetes who cannot make […] Continue reading -> India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> Pakistan, Afghanistan & Yemen Among Countries With Biggest Vaccine Supply Gaps; US Promises More Jabs for Conflict Zones 11/11/2021 Elaine Ruth Fletcher Pakistan and eight other countries, mostly in or around conflict zones, face the largest gaps in vaccine commitments needed to reach a WHO goal of 70% coverage by September 2022. The data is part of a new “COVID Global Tracker” – launched Wednesday during a first-ever meeting of the world’s foreign ministers, convened by US […] Continue reading -> Launching the ‘African Medicines Agency Countdown’ 05/11/2021 Editorial team More than half of the African Union’s 55 member states have now signed the African Medicines Agency Treaty. As the countdown begins for other nations to sign, Health Policy Watch will be keeping track on our newly-launched AMA Countdown, website developed in collaboration with the African Medicines Agency Treaty Alliance. Here you can find the […] Continue reading -> ‘Zero Draft’ Report on WHO Reform Punts Pandemic Treaty Forward – Amidst Signals of US Warming to Initiative 28/10/2021 Elaine Ruth Fletcher A “Zero Draft” report by a WHO Working Group gives cautious endorsement to advancing negotiations over a new “Pandemic Treaty” among WHO’s 194 member states. That endorsement by the Working Group of member states remains couched in highly nuanced, diplomatic language that makes it clear how big the lift may be to actually negotiate a […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... Write a Comment... Email (Required) Name (Required) Website
India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> Pakistan, Afghanistan & Yemen Among Countries With Biggest Vaccine Supply Gaps; US Promises More Jabs for Conflict Zones 11/11/2021 Elaine Ruth Fletcher Pakistan and eight other countries, mostly in or around conflict zones, face the largest gaps in vaccine commitments needed to reach a WHO goal of 70% coverage by September 2022. The data is part of a new “COVID Global Tracker” – launched Wednesday during a first-ever meeting of the world’s foreign ministers, convened by US […] Continue reading -> Launching the ‘African Medicines Agency Countdown’ 05/11/2021 Editorial team More than half of the African Union’s 55 member states have now signed the African Medicines Agency Treaty. As the countdown begins for other nations to sign, Health Policy Watch will be keeping track on our newly-launched AMA Countdown, website developed in collaboration with the African Medicines Agency Treaty Alliance. Here you can find the […] Continue reading -> ‘Zero Draft’ Report on WHO Reform Punts Pandemic Treaty Forward – Amidst Signals of US Warming to Initiative 28/10/2021 Elaine Ruth Fletcher A “Zero Draft” report by a WHO Working Group gives cautious endorsement to advancing negotiations over a new “Pandemic Treaty” among WHO’s 194 member states. That endorsement by the Working Group of member states remains couched in highly nuanced, diplomatic language that makes it clear how big the lift may be to actually negotiate a […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... Write a Comment... Email (Required) Name (Required) Website
Pakistan, Afghanistan & Yemen Among Countries With Biggest Vaccine Supply Gaps; US Promises More Jabs for Conflict Zones 11/11/2021 Elaine Ruth Fletcher Pakistan and eight other countries, mostly in or around conflict zones, face the largest gaps in vaccine commitments needed to reach a WHO goal of 70% coverage by September 2022. The data is part of a new “COVID Global Tracker” – launched Wednesday during a first-ever meeting of the world’s foreign ministers, convened by US […] Continue reading -> Launching the ‘African Medicines Agency Countdown’ 05/11/2021 Editorial team More than half of the African Union’s 55 member states have now signed the African Medicines Agency Treaty. As the countdown begins for other nations to sign, Health Policy Watch will be keeping track on our newly-launched AMA Countdown, website developed in collaboration with the African Medicines Agency Treaty Alliance. Here you can find the […] Continue reading -> ‘Zero Draft’ Report on WHO Reform Punts Pandemic Treaty Forward – Amidst Signals of US Warming to Initiative 28/10/2021 Elaine Ruth Fletcher A “Zero Draft” report by a WHO Working Group gives cautious endorsement to advancing negotiations over a new “Pandemic Treaty” among WHO’s 194 member states. That endorsement by the Working Group of member states remains couched in highly nuanced, diplomatic language that makes it clear how big the lift may be to actually negotiate a […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... Write a Comment... Email (Required) Name (Required) Website
Launching the ‘African Medicines Agency Countdown’ 05/11/2021 Editorial team More than half of the African Union’s 55 member states have now signed the African Medicines Agency Treaty. As the countdown begins for other nations to sign, Health Policy Watch will be keeping track on our newly-launched AMA Countdown, website developed in collaboration with the African Medicines Agency Treaty Alliance. Here you can find the […] Continue reading -> ‘Zero Draft’ Report on WHO Reform Punts Pandemic Treaty Forward – Amidst Signals of US Warming to Initiative 28/10/2021 Elaine Ruth Fletcher A “Zero Draft” report by a WHO Working Group gives cautious endorsement to advancing negotiations over a new “Pandemic Treaty” among WHO’s 194 member states. That endorsement by the Working Group of member states remains couched in highly nuanced, diplomatic language that makes it clear how big the lift may be to actually negotiate a […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
‘Zero Draft’ Report on WHO Reform Punts Pandemic Treaty Forward – Amidst Signals of US Warming to Initiative 28/10/2021 Elaine Ruth Fletcher A “Zero Draft” report by a WHO Working Group gives cautious endorsement to advancing negotiations over a new “Pandemic Treaty” among WHO’s 194 member states. That endorsement by the Working Group of member states remains couched in highly nuanced, diplomatic language that makes it clear how big the lift may be to actually negotiate a […] Continue reading -> Posts navigation Older posts